Differentially expressed gene profiles in the serum before and after the ultrasound-guided ethanol sclerotherapy in patients with ovarian endometriomas
article
OA: closed
CC0
⤵ 4 in-corpus citations
AI-generated summary
This study analyzed differences in serum gene expression profiles before and after ultrasound-guided ethanol sclerotherapy to identify potential biomarkers for ovarian endometriomas.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
ObjectivesTo detect the differentially expressed genes and subsequently identify disease-related signatures and potential biomarkers for patients with ovarian endometriomas in the serum before and after the ultrasound-guided ethanol sclerotherapy in patients with ovarian endometriomas.Design and methodsVenous blood samples were collected from nine patients with ovarian endometriomas before and after ultrasound-guided ethanol sclerotherapy, and the serum were isolated after centrifugation. NimbleGen human gene expression microarrays analysis was conducted to analyse gene ontology categories (GO terms) and signalling pathways of differentially expressed genes. The accuracy of some typical genes from microarray analysis was verified by quantitative PCR (qPCR).ResultsApproximately 45,033 genes were analysed by NimbleGen human gene expression microarrays, which identified 447 genes that showed differential expressions before and after therapy. Of these, 225 genes were up-regulated and 222 genes were down-regulated. The GO terms of the down-regulated genes were strongly associated with the pathogenesis of ovarian endometriomas; 15 down-regulated genes showed overlaps in both signalling pathways and GO terms. Among these, six genes showed statistical significance including IL6, CD36, JUNB, B4GALT1, HES1, and NR4A1, which were also validated by qPCR analysis.ConclusionsThere were differentially expressed genes in the serum before and after ultrasound-guided ethanol sclerotherapy in patients with ovarian endometriomas. Notably, the expressions of IL6, CD36, JUNB, B4GALT1, HES1, and NR4A1, which are strongly associated with the pathogenesis of ovarian endometriomas, were significantly down-regulated after ethanol sclerotherapy. This may not only help us understand EMs pathogenesis, but also provide potential biomarkers for verifying the effects of ethanol sclerotherapy.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood (2-hop)
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]
References (37)
- Altered gene expression and secretion of interleukin-6 in stromal cells derived from endometriotic tissues via openalex
- [Changes of tumor necrosis factor alpha and interleukin-6 levels in peritoneal fluid of patients with endometriosis and their effects on human sperm motility and mouse embryo development]. via openalex
- Correlation between ovarian chocolate cyst and serum carbohydrate antigen 125 level and the effect of ultrasound‐guided interventional sclerotherapy on serum carbohydrate antigen 125 level via openalex
- Effectiveness of ultrasound-guided aspiration and sclerotherapy with 95% ethanol for treatment of recurrent ovarian endometriomas via openalex
- Elevated levels of macrophage migration inhibitory factor in the peripheral blood of women with endometriosis via openalex
- Endometrial and peritoneal expression of aromatase, cytokines, and adhesion factors in women with endometriosis via openalex
- Gonadotropin-releasing hormone agonist treatment reduced serum interleukin-6 concentrations in patients with ovarian endometriomas via openalex
- Higher activity by opaque endometriotic lesions than nonopaque lesions via openalex
- Interferon‐Gamma (IFN‐γ) and Interleukin‐6 (IL‐6) in Peritoneal Fluid and Macrophage‐Conditioned Media of Women With Endometriosis via openalex
- Interleukin-6 and other soluble factors in peritoneal fluid and endometriomas and their relation to pain and aromatase expression via openalex
- Laparoscopic Surgery for the Management of Ovarian Endometrioma via openalex
- Marked elevation of macrophage migration inhibitory factor in the peritoneal fluid of women with endometriosis via openalex
- Ovarian endometrioma but not deep infiltrating endometriosis is associated with increased serum levels of interleukin-8 and interleukin-6 via openalex
- Transcriptional expression of type-I interferon response genes and stability of housekeeping genes in the human endometrium and endometriosis via openalex
- Ultrasound-guided aspiration and ethanol sclerotherapy for treating endometrial cysts via openalex
- W2080866755 via openalex
- W2085124463 via openalex
- W2118598742 via openalex
- W2144458244 via openalex
- W2241063488 via openalex
- W2357449333 via openalex
- W2405262285 via openalex
- W6713807587 via openalex
- W1787839452 via openalex
- W1838548664 via openalex
- W1954862601 via openalex
- W1965502287 via openalex
- W1968199586 via openalex
- W1972238505 via openalex
- W1980447854 via openalex
- W1991340894 via openalex
- W2005435407 via openalex
- W2032345589 via openalex
- W2041563335 via openalex
- W2045264967 via openalex
- W2064760068 via openalex
- W2072924660 via openalex
Cited by (4)
- Identification of key modules and candidate genes associated with endometriosis based on transcriptome data via bioinformatics analysis 2023
- Pelvic Artificial Isolation with Ultrasound-Guided Fluid: A New Technique In Ovarian Endometriotic Cyst Transabdominal Sclerotherapy 2022
- Bis-Indole–Derived Nuclear Receptor 4A1 (NR4A1, Nur77) Ligands as Inhibitors of Endometriosis 2020
- Endometrioma ethanol sclerotherapy could increase IVF live birth rate in women with moderate-severe endometriosis 2020
Source provenance
- europepmc
- last seen: 2026-09-27T09:11:36.575535+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-05-13T22:17:52.213533+00:00
- unpaywall
- last seen: 2026-09-30T06:35:30.012611+00:00
License: CC0
· commercial use OK